Medical Communications

The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …

Gilead has broken the news that its apoptosis signal-regulating kinase 1 (ASK1) inhibitor selonsertib failed to meet its primary endpoint …

The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …

Eli Lilly has revealed it is to withdraw its platelet-derived growth factor receptor alpha (PDGFR-α) blocking antibody Lartruvo (olaratumab) from …

Global spending on the fight against malaria has stalled, falling $2 billion short of World Health Organization (WHO) targets, according …

An international team of researchers have identified an “Achilles’ heel” protein that could lead to the development of novel treatments …

Pharmacists should review older people’s medicines regimens in order to reduce inappropriate polypharmacy, according to the Royal Pharmaceutical Society (RPS). …

The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …

 NDA would like to invite you to join  Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …

This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …